Maurizio Borsato
Research Subjects
Research Interests
Maurizio Borsato has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Forti
Anestesia and Intensive Care Department, Treviso Regional Hospital, Italy
1 shared publication - Carlo Sorbara
Department of Anaesthesia and Intensive Care, Intraoperative and Critical Care Neurophysiology in Cardiac Surgery, Treviso Regional Hospital, Azienda Ospedaliera Ulss 9, Piazzale Ospedale 1, 31100, Treviso, Italy.
1 shared publication - Carlo Valfrè
Cardiovascular Disease Department, Treviso Regional Hospital, Italy
1 shared publication - Carolina Longo
Regional Project for the Reduction of Neurodysfunction after Cardiac Surgery and Neurosurgery, Improvement of Multimodality Neuromonitoring, Regione Veneto, Italy
1 shared publication - Enrico Bosco
Department of Anaesthesia and Intensive Care, Intraoperative and Critical Care Neurophysiology in Cardiac Surgery, Treviso Regional Hospital, Azienda Ospedaliera Ulss 9, Piazzale Ospedale 1, 31100, Treviso, Italy.
1 shared publication - Fabrizio Baldanzi
Neurophysiopathology Unit, University Hospital of Careggi, University of Florence, 50134 Firenze, Italy
1 shared publication
Latest Publications
- Open Access
- 4 February 2010
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 5 (1) , 5
Microembolic signals and strategy to prevent gas embolism during extracorporeal membrane oxygenation
Extracorporeal membrane oxygenation (ECMO) supplies systemic blood perfusion and gas exchange in patients with cardiopulmonary failure. The current literature lacks of papers reporting the possible risks of microembolism among the complications of this treatment.
- 4 February 2010
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 5 (1) , 5
Open AccessMicroembolic signals and strategy to prevent gas embolism during extracorporeal membrane oxygenation
Extracorporeal membrane oxygenation (ECMO) supplies systemic blood perfusion and gas exchange in patients with cardiopulmonary failure. The current literature lacks of papers reporting the possible risks of microembolism among the complications of this treatment.